FIVE PRIME ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of FPRX and Encourages Investors to Contact the Firm Biotech Investing
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical Biotech Investing
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom's Regulatory Food Safety Agency Biotech Investing
 Gilead to Present New Data at CROI 2021 Demonstrating the Company's Commitment to Addressing Urgent Global Health Needs Biotech Investing
Aptose to Release Fourth Quarter and Year End December 31, 2020 Financial Results and Hold Conference Call on March 23, 2021 Biotech Investing
BLINCYTO® Demonstrated Significantly Prolonged Event-Free Survival Compared With Consolidation Chemotherapy In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia Biotech Investing
Terra Nova Resources Inc. Announces Conditional Approval of Fundamental Change and Announces Effective Date for Name Change and Share Consolidation Biotech Investing
